Results 181 to 190 of about 79,953 (279)

Pediatric Non‐Lupus Full House Nephropathy: Case Report and Review of Literature

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Lupus nephritis is a severe manifestation of systemic lupus erythematosus (SLE) typically characterized by glomerular “full‐house” immunofluorescence. However, non‐lupus nephropathies may occasionally exhibit similar patterns, creating diagnostic uncertainty.
Mohammad Firoz Anjum, Suraj Sah, Inesh Khanal, Sharmila Gainju, Sri Ram K.C.   +4 more
wiley   +1 more source

The molecular landscape of AL amyloidosis. [PDF]

Br J Haematol
Zvida-Bloch T, Muchtar E, Dispenzieri A, Shpilberg O, Hershkovitz-Rokah O.   +4 more
europepmc   +1 more source

Lymphangioma‐Induced Macroglossia in an Adolescent: A Case Report

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Lymphangioma is a congenital malformation of the lymphatic system, commonly affecting the head and neck region. Macroglossia due to lymphangioma in adolescence is uncommon, making this case noteworthy. This condition can affect oral function, speech, and quality of life, making early diagnosis and intervention essential. This report highlights
Arezoo Heidary, Mojtaba Mehrabanian
wiley   +1 more source

Comparative evaluation of free light chain assays in AL amyloidosis: Performance of Sebia versus Freelite and N-Latex. [PDF]

Pract Lab Med
Zhao F, Pretorius C, Mollee P.
europepmc   +1 more source

Sequential Dermoscopic, Histopathologic, and Immunopathologic Documentation of Regressing Seborrheic Keratosis: A Multimodal, Time‐Resolved Visual Case Study

Clinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Seborrheic keratosis (SK) typically shows stable behavior, and spontaneous regression is rarely documented. We report a unique case of SK that underwent complete involution within 8 weeks. Sequential clinical and dermoscopic imaging demonstrated a transition from classical SK structures to red‐blue homogeneous areas and, ultimately, to whitish
Tomoaki Takada
wiley   +1 more source

Rapamycin Reduces Amyloid‐β Plaques and Improves Behavioral Performance in a Sex‐Dependent Manner in Mouse Models of Amyloidosis

CNS Neuroscience &Therapeutics, Volume 32, Issue 3, March 2026.
Rapamycin treatment reduced cerebral Aβ plaque burden, alleviated neuritic dystrophy, suppressed glial hyperactivation, and increased plaque‐associated microglial recruitment in amyloidosis mouse models, resulting in improved memory performance. Mechanistically, rapamycin enhanced microglial lysosomal degradation, facilitated lipid droplet clearance in
Shihui Guo, Weishan Fu, Yating Wang, Qi Liu, Jiaxin Li, Kai Guo, Hongsheng Zhang   +6 more
wiley   +1 more source

Real-World Data of Light Chain (AL) Amyloidosis: Prognostic Indices and Treatment Patterns. [PDF]

Biomedicines
Mitrovic M, Sretenovic A, Kecman N, Vukosavljevic N, Perunicic Jovanovic M, Sobic Saranovic D, Maksimovic R, Bukumiric Z, Lekovic D, Ristic A, Todorovic Balint M, Bila J.   +11 more
europepmc   +1 more source

Therapeutic Efficacy and Safety Profile of Eplontersen in Hereditary Transthyretin‐Mediated Amyloidosis: A Systematic Review

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background Hereditary transthyretin‐mediated amyloidosis (hATTR) is a disorder that affects several body systems and can result in life‐threatening conditions like cardiomyopathy and polyneuropathy. For treatment of hATTR in the new medical realm, there is a breakthrough discovery of a medicine called Eplontersen, which targets the underlying ...
Zeel Vishnubhai Patel, Verkha Kumari, Paras, Bethineedi Lakshmi Deepak, Priyadarshi Prajjwal, Kolanu Nikhil Deep, Rakhi Bai, Serene Sara John, Omniat Amir Hussin   +8 more
wiley   +1 more source

Dermatological Manifestations of Amyloid Light-Chain (AL) Amyloidosis: A Case Report Highlighting Early Diagnosis and Treatment. [PDF]

Cureus
Gill SS, Kamboj T.
europepmc   +1 more source

A Narrative Review on Integrative Bioinformatics Approaches for microRNA Research in Familial Mediterranean Fever: Current Insights and Future Directions

Health Science Reports, Volume 9, Issue 3, March 2026.
ABSTRACT Background and Aims Familial Mediterranean Fever (FMF) is a monogenic autoinflammatory disease caused by mutations in the MEFV gene, resulting in recurrent inflammatory episodes and a risk of developing amyloidosis. Although its pathophysiology is well described, FMF still lacks specific biomarkers and personalized treatment strategies ...
Zeinab Skaineh, Razane Hammoud, Ahlam Chaaban, Eliana Eldawra, José‐Noel Ibrahim   +4 more
wiley   +1 more source